IL6 and type 2 diabetes mellitus: It is hypothesized that sustained inflammatory responses—characterized by elevated levels of biomarkers such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α)—may contribute to the development of insulin resistance, a central feature in the pathogenesis of T2D.